HealthEquity, Inc. (NASDAQ:HQY) Director Sells $639,917.50 in Stock

HealthEquity, Inc. (NASDAQ:HQYGet Free Report) Director Robert W. Selander sold 5,750 shares of the business’s stock in a transaction that occurred on Monday, February 10th. The stock was sold at an average price of $111.29, for a total value of $639,917.50. Following the sale, the director now directly owns 78,219 shares in the company, valued at $8,704,992.51. The trade was a 6.85 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website.

HealthEquity Stock Down 1.1 %

Shares of NASDAQ:HQY opened at $112.69 on Friday. HealthEquity, Inc. has a 52-week low of $65.01 and a 52-week high of $115.59. The stock has a market cap of $9.77 billion, a P/E ratio of 103.39, a price-to-earnings-growth ratio of 1.61 and a beta of 0.55. The business’s 50 day moving average is $102.14 and its 200 day moving average is $90.76. The company has a quick ratio of 3.20, a current ratio of 3.20 and a debt-to-equity ratio of 0.51.

HealthEquity (NASDAQ:HQYGet Free Report) last posted its earnings results on Monday, December 9th. The company reported $0.59 earnings per share for the quarter, missing analysts’ consensus estimates of $0.71 by ($0.12). HealthEquity had a return on equity of 9.70% and a net margin of 8.41%. During the same period in the previous year, the business posted $0.40 EPS. Sell-side analysts predict that HealthEquity, Inc. will post 2.32 EPS for the current year.

Institutional Trading of HealthEquity

A number of hedge funds have recently bought and sold shares of the stock. Ameritas Investment Partners Inc. lifted its holdings in HealthEquity by 0.3% during the fourth quarter. Ameritas Investment Partners Inc. now owns 33,856 shares of the company’s stock worth $3,248,000 after buying an additional 88 shares during the period. Smartleaf Asset Management LLC lifted its holdings in HealthEquity by 34.3% during the fourth quarter. Smartleaf Asset Management LLC now owns 384 shares of the company’s stock worth $37,000 after buying an additional 98 shares during the period. Louisiana State Employees Retirement System lifted its holdings in HealthEquity by 0.4% during the fourth quarter. Louisiana State Employees Retirement System now owns 24,200 shares of the company’s stock worth $2,322,000 after buying an additional 100 shares during the period. Oregon Public Employees Retirement Fund lifted its holdings in shares of HealthEquity by 0.6% during the 4th quarter. Oregon Public Employees Retirement Fund now owns 17,776 shares of the company’s stock valued at $1,706,000 after purchasing an additional 100 shares during the last quarter. Finally, State of Michigan Retirement System lifted its holdings in shares of HealthEquity by 0.5% during the 4th quarter. State of Michigan Retirement System now owns 20,722 shares of the company’s stock valued at $1,988,000 after purchasing an additional 100 shares during the last quarter. Hedge funds and other institutional investors own 99.55% of the company’s stock.

Wall Street Analyst Weigh In

Several equities research analysts have weighed in on HQY shares. Bank of America boosted their price objective on HealthEquity from $100.00 to $120.00 and gave the stock a “buy” rating in a research note on Wednesday, November 13th. Barrington Research upped their target price on HealthEquity from $105.00 to $120.00 and gave the company an “outperform” rating in a research note on Monday, December 2nd. JMP Securities upped their target price on HealthEquity from $105.00 to $107.00 and gave the company a “market outperform” rating in a research note on Tuesday, December 10th. BTIG Research upped their target price on HealthEquity from $110.00 to $130.00 and gave the company a “buy” rating in a research note on Thursday, November 14th. Finally, Mizuho initiated coverage on HealthEquity in a research note on Wednesday, December 4th. They set an “outperform” rating and a $126.00 target price on the stock. One analyst has rated the stock with a hold rating and thirteen have issued a buy rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $110.71.

Get Our Latest Research Report on HealthEquity

HealthEquity Company Profile

(Get Free Report)

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.

Featured Stories

Insider Buying and Selling by Quarter for HealthEquity (NASDAQ:HQY)

Receive News & Ratings for HealthEquity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthEquity and related companies with MarketBeat.com's FREE daily email newsletter.